Ventyx Biosciences, Inc.

NASDAQ:VTYX

2.37 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 40.925141.89851.57956.6151.71763.66964.819263.2745.34341.6970.79168.986102.788-0.2440.244-0.309
Short Term Investments 198.513160.684200.641244.209280.535313.246253.122149.153205.109212.656187.78572.96600.48800.618
Cash and Short Term Investments 239.438302.582252.22300.819332.252376.915356.613412.423250.452254.346258.576141.952102.7880.2440.2440.309
Net Receivables 0.50.60.8000.0490000000000
Inventory 00-0.80000000000000
Other Current Assets 16.99316.57712.1257.27314.44910.08712.7475.9671.7413.1594.4443.7072.2400.0010
Total Current Assets 256.931319.759264.345308.092346.701387.051330.688418.39252.193257.505263.02145.659105.0280.2440.2450.309
Non-Current Assets:
Property, Plant & Equipment, Net 10.92411.24212.27112.5321.962.0221.9441.9832.021.5870.2540.2190.072000
Goodwill 0000000000000000
Intangible Assets 0000000000000000
Goodwill and Intangible Assets 00-3.4560000000000000
Long Term Investments 41.2360.9750.9750.9750038.67207.918.80128.14800000
Tax Assets 002.4810000000000000
Other Non-Current Assets 0.1020.1021.0770.1020.1020.0960.0960.0720.0720.060.062.8310.816-0.2440-0.309
Total Non-Current Assets 52.26212.31913.34813.6092.0622.11840.7122.0559.99220.44828.4623.050.888-0.2440-0.309
Total Assets 309.193332.078277.693321.701348.763389.169371.4420.445262.185277.953291.482148.709105.91600.2450
Liabilities & Equity:
Current Liabilities:
Account Payables 6.5835.5835.7569.3384.0856.5526.43318.5825.8057.1144.6614.2632.37301.1020
Short Term Debt 0.9710.9461.0010.4790.4390.4260.4120.3950.3860.278000000
Tax Payables 0000000000000000
Deferred Revenue 00000000-0.3860000000
Other Current Liabilities 10.558.00515.50816.39115.519.5379.51416.68411.86910.3997.6227.5465.69100.3010
Total Current Liabilities 18.10414.53422.26526.20820.03416.51516.35935.66117.67417.79112.28311.8098.06401.4030
Non-Current Liabilities:
Long Term Debt 10.29410.54811.50511.8530.9221.0361.1461.2511.3591.0390224.5210012.6470
Deferred Revenue Non-Current 0000000000000000
Deferred Tax Liabilities Non-Current 002.4810000000000000
Other Non-Current Liabilities 00-2.481000-00004.6610173.716016.8490
Total Non-Current Liabilities 10.29410.54811.50511.8530.9221.0361.1461.2511.3591.0394.661224.521173.716029.4960
Total Liabilities 28.39825.08233.7738.06120.95617.55117.50536.91219.03318.8312.283236.33181.78030.8990
Equity:
Preferred Stock 00000000000148.709173.716000
Common Stock 0.0070.0070.0060.0060.0060.0060.0060.0060.0050.0050.00500.004000
Retained Earnings -489.709-457.759-419.187-372.434-318.407-265.156-226.225-191.011-160.549-140.531-117.799-100.031-87.2570-32.5010
Accumulated Other Comprehensive Income/Loss -0.248-0.121-0.05-0.507-0.71-0.561-1.123-1.312-1.291-0.958-0.0580.017-0.012-30.6540-4.128
Other Total Stockholders Equity 770.745764.869663.154656.575646.9180.5551.117575.85404.987400.607397.05112.393-162.31501.8470
Total Shareholders Equity 280.795306.996243.923283.64327.807-265.156-226.225383.533243.152259.123279.199-87.621-75.864-30.654-30.654-4.128
Total Equity 280.795306.996243.923283.64327.807-265.156-226.225383.533243.152259.123279.199-87.621-75.864-30.654-30.654-4.128
Total Liabilities & Shareholders Equity 309.193332.078277.693321.701348.763-247.605-208.72420.445262.185277.953291.482148.709105.916-30.6540.245-4.128